34 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
26 Feb 24
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
8:30am
at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
oThe poster showed Cogent’s internally-developed
8-K
EX-99.2
be1mp
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:12am
8-K
EX-99.1
rpsdl6n
15 Mar 22
Cogent Biosciences Provides Corporate Updates, Fourth Quarter
8:08am
8-K
EX-99.1
3brby5
10 Nov 21
Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results
8:05am
424B5
bfe76uw2 ibic2m0m
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
j8ll9
30 Nov 20
Prospectus supplement for primary offering
5:28pm